🇺🇸 Haloperidol-Haloperidol in United States

87 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Agitation — 13 reports (14.94%)
  2. Neuroleptic Malignant Syndrome — 11 reports (12.64%)
  3. Dehydration — 9 reports (10.34%)
  4. Drug Interaction — 9 reports (10.34%)
  5. Dystonia — 8 reports (9.2%)
  6. Renal Failure Acute — 8 reports (9.2%)
  7. Toxicity To Various Agents — 8 reports (9.2%)
  8. Anxiety — 7 reports (8.05%)
  9. Hyponatraemia — 7 reports (8.05%)
  10. Nausea — 7 reports (8.05%)

Source database →

Haloperidol-Haloperidol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Haloperidol-Haloperidol approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Haloperidol-Haloperidol in United States?

New York State Psychiatric Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.